DMD and Duchenne muscular dystrophy: Experimental therapies for DMD, such as antisense oligonucleotide-mediated exon skipping to restore dystrophin protein, are in clinical trials [11], [12], although quantitative methods of measuring dystrophin restoration currently require muscle biopsy.